| Patents for C12N 5 - Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor (182,629) |
|---|
| 05/08/1997 | CA2189499A1 Immortalised embryonic hippocampal cells and their use |
| 05/07/1997 | EP0771878A1 Plants with reduced glucosinolate content |
| 05/07/1997 | EP0771358A1 Isolated nucleic acid molecule which codes for a tumor rejection antigen precursor, and uses thereof |
| 05/07/1997 | EP0771356A1 Methods for the preparation of retroviral particles and cell lines deficient in the alpha-galactosyl epitope |
| 05/07/1997 | EP0771352A1 Lkp pilin structural genes and operon of nontypable haemophilus influenzae |
| 05/07/1997 | EP0771350A1 Growth control for cells encapsulated within bioartificial organs |
| 05/07/1997 | EP0771348A1 Bradykinin b2 receptor modified transgenic non-human animals |
| 05/07/1997 | EP0771327A1 Contraceptive vaccine |
| 05/07/1997 | EP0771320A1 Polynucleotide decoys that ihnibit mhc-ii expression and uses thereof |
| 05/07/1997 | EP0771212A1 Contraceptive vaccine |
| 05/07/1997 | EP0771193A1 Activation of growth factors by matrix vesicles |
| 05/07/1997 | EP0686202A4 Prenatal screening |
| 05/07/1997 | EP0668917B1 Riboflavin synthesis in yeast |
| 05/07/1997 | EP0610423B1 Prevascularized polymeric implants for organ transplantation |
| 05/07/1997 | EP0566571B1 Diagnosis of metastatic cancer by the mts-1 gene |
| 05/07/1997 | EP0476093B1 Production of improved rapeseed exhibiting a reduced saturated fatty acid content |
| 05/07/1997 | EP0464155B1 Endothelial cell growth factor, isolation and expression |
| 05/07/1997 | DE19540902A1 Protein mit Anti-Tumorwirkung Protein with anti-tumor activity |
| 05/07/1997 | CN1149319A Angiostatin and method of use for inhibition of Angiogenesis |
| 05/07/1997 | CN1149318A Luciferases |
| 05/07/1997 | CN1149317A DNA sequences |
| 05/07/1997 | CN1149316A Blood-borne mesenchymal cells |
| 05/07/1997 | CN1149299A Anti-GP39 antibodies and uses therefor |
| 05/07/1997 | CN1149258A Inhibin compositions and methods of use thereof |
| 05/07/1997 | CN1149257A Isolated tumor rejection antigen precursor mage-2 derived peptides, and uses thereof |
| 05/06/1997 | US5627274 Antisense oligonucleotides which combat aberrant splicing and methods of using the same |
| 05/06/1997 | US5627264 Chimeric complement inhibitor proteins |
| 05/06/1997 | US5627213 For blood cytometry, aliphatic aldehyde, polyhydric alcohol, acid salt |
| 05/06/1997 | US5627155 Controlling diseases with proteins such as allergies, psoriasis, tissue rejection and autoimmune diseases |
| 05/06/1997 | US5627073 Hybridomas producing antibodies to cardiac hypertrophy factor |
| 05/06/1997 | US5627044 Compositions and methods for protein structural determinations |
| 05/06/1997 | US5627023 Enzyme inhibitors for treatment of aids, cell culture and genetic engineerng |
| 05/06/1997 | US5627021 Three-dimensional co-culture process |
| 05/06/1997 | US5626863 Photopolymerizable biodegradable hydrogels as tissue contacting materials and controlled-release carriers |
| 05/02/1997 | EP0770680A2 Lymphocyte-associated cell surface protein |
| 05/02/1997 | EP0770677A2 Improved sustainable chicken cell line for the production of Marek's disease vaccines |
| 05/02/1997 | EP0770396A2 Use of new factor VIII coagulant polypeptides |
| 05/02/1997 | EP0770141A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-1 AND 2 |
| 05/02/1997 | EP0770137A1 Improvements in production of proteins in host cells |
| 05/02/1997 | EP0770136A1 Method for selecting high-expressing host cells |
| 05/02/1997 | EP0770135A1 Novel compounds |
| 05/02/1997 | EP0770133A1 Adenovirus comprising a gene coding for an no synthase |
| 05/02/1997 | EP0770130A1 METHOD FOR IDENTIFYING NUCLEIC ACIDS ENCODING c-fos PROMOTER ACTIVATING PROTEINS |
| 05/02/1997 | EP0770128A1 Ikaros transgenic cells and animals |
| 05/02/1997 | EP0770125A1 Primate embryonic stem cells |
| 05/02/1997 | EP0770094A1 Modified g-protein coupled receptors |
| 05/02/1997 | EP0769968A1 Retroviral vectors produced by producer cell lines resistant to lysis by human serum |
| 05/02/1997 | EP0769952A1 Chicken infectious anemia virus vaccine |
| 05/02/1997 | EP0769903A1 Inducible nitric oxide synthase gene for treatment of disease |
| 05/02/1997 | EP0769902A1 Methods for reducing hyperacute rejection of xenografts |
| 05/02/1997 | EP0769898A1 ENDO-1,4-beta -GLUCANASE GENES AND THEIR USE IN PLANTS |
| 05/02/1997 | EP0328552B2 Thrombin derived polypeptides, compositions and methods for use |
| 05/01/1997 | WO1997015686A1 Diagnosis of susceptibility to cancer and treatment thereof |
| 05/01/1997 | WO1997015681A1 Methods for isolating polyhydroxyalkanoates from plants |
| 05/01/1997 | WO1997015673A1 Process for preparing o-acetylserine, l-cysteine and l-cysteine-related products |
| 05/01/1997 | WO1997015671A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | WO1997015667A1 Biologically active eph family ligands |
| 05/01/1997 | WO1997015666A1 Therapeutic antiangiogenic compositions and methods |
| 05/01/1997 | WO1997015664A1 Intensive homologous promoter obtained from hamsters |
| 05/01/1997 | WO1997015663A1 A novel haemopoietin receptor and genetic sequences encoding same |
| 05/01/1997 | WO1997015662A2 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 05/01/1997 | WO1997015655A2 New artificial tissue, method for the production and the use thereof |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015319A1 Method and pharmaceutical composition for chondrostimulation with a prostaglandin (e.g. misoprostol) and tgf-beta, optionally in combination with igf-1 |
| 05/01/1997 | WO1997015310A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | WO1997015243A1 Induction of immunological tolerance |
| 05/01/1997 | WO1997015195A1 Hybrid matrix implants and explants |
| 05/01/1997 | WO1997000941A3 Novel system for multilayer growth of anchorage-dependent cells |
| 05/01/1997 | WO1996040925A3 Regulatory elements conferring tapetum specificity |
| 05/01/1997 | CA2238940A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | CA2235801A1 Modification of soluble solids using sucrose phosphate synthase encoding sequence |
| 05/01/1997 | CA2235575A1 Novel human cysteine protease |
| 05/01/1997 | CA2235509A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | CA2235368A1 Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor |
| 05/01/1997 | CA2232241A1 Diagnosis of susceptibility to cancer and treatment thereof |
| 05/01/1997 | CA2204906A1 Neurotrophin antagonists |
| 05/01/1997 | CA2161863A1 Angiogenic material and uses thereof |
| 04/30/1997 | DE19539952A1 Verfahren zur Herstellung von O-Acetylserin, L-Cystein und L-Cystein-verwandten Produkten A process for preparing O-acetylserine, L-cysteine and L-cysteine-related products |
| 04/30/1997 | DE19539493A1 Starker homologer Promotor aus Hamster Powerful homologous promoter from hamsters |
| 04/30/1997 | CN1148869A Method for producing cytoplasmic male sterility in plants and use thereof in production of hybrid seed |
| 04/29/1997 | US5625136 Synthetic DNA sequence having enhanced insecticidal activity in maize |
| 04/29/1997 | US5625126 Transgenic non-human animals for producing heterologous antibodies |
| 04/29/1997 | US5625123 Neurotrophin-3-deficient embryonic stem cells and mice and their use |
| 04/29/1997 | US5625121 Mice deficient in nerve growth factor receptors encoded by trkB |
| 04/29/1997 | US5625048 Modified green fluorescent proteins |
| 04/29/1997 | US5625039 Anti-human IgE monoclonal antibodies |
| 04/29/1997 | US5624899 Ligands and proteins |
| 04/29/1997 | US5624840 Grafting cells and tissues |
| 04/29/1997 | US5624839 Process for culturing hepatocytes for formation of spheroids |
| 04/29/1997 | US5624838 Kit containing colored plant culture medium |
| 04/29/1997 | US5624837 Nucleic acid encoding chimeric complement inhibitor proteins |
| 04/29/1997 | US5624832 β1 6 N-acetylglucosaminyltransferase, its acceptor molecule, leukosialin, and a method for cloning proteins having enzymatic activity |
| 04/29/1997 | US5624830 Selectivity killing mammalian host cells in vitro |
| 04/29/1997 | US5624827 DNA sequences encoding the plant toxin gelonin |
| 04/29/1997 | US5624819 Dna, nucleic acid detectors, mutant genes and genetic engineering |
| 04/29/1997 | US5624806 Antibodies to cardiac hypertrophy factor and uses thereof |
| 04/29/1997 | US5624801 Methods of identifying human osteoclast-specific and related genes |
| 04/29/1997 | US5624795 Isolation and characterization of a novel chimpanzee lentivirus, designated simian immunodeficiency virus isolate cpz-ant |
| 04/29/1997 | US5624679 Methods and compositions for poly-β-1-4-N-acetylglucosamine biological barriers |
| 04/29/1997 | US5624672 Compositions which inhibit apoptosis, methods of purifying the compositions and uses thereof |